PIK3CA and ovarian carcinoma: Advances in ovarian cancer diagnosis include the use of genetic testing to identify mutated genes associated with epithelial ovarian cancer in patients, with a known family history of breast and ovarian cancer, such as TP53, PIK3CA, KRAS, and BRCA1/2 [2,8].